Aprogen Biologics Inc (003060)

Aprogen Biologics Inc recorded a significant insider purchase on September 23, 2026, involving 12.7 million shares valued at approximately 20 billion KRW. This transaction represents a 2.05% increase in float ownership. Despite a 23.6% decline in stock price over the last ninety days, this singular acquisition remains the only recent activity reported.
Ticker: 003060 Exchange: KSC


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Aprogen,Inc. ((주)에이프로젠) No position specified Large shareholder
Transaction date
Purchase
Price
151.48
Quantity 62,262 -31.2%
Value ₩4,545,620
GenExel-Sein, Inc (제넥셀세인(주)) Unclassified position Large shareholder
Transaction date
Sale
Price
181.35
Quantity 68,852 +44.9%
Value ₩3,020,603
KIM JAESEOB (김 재섭) Director (이사) Director Large shareholder
Transaction date
Purchase
Price
335.66
Quantity 22,952 +38.3%
Value ₩1,803,175
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-02 2026-09-23 B Purchase Aprogen,Inc. ((주)에이프로젠)

No position specified

Large shareholder
62,262 -31.2%
151.48
₩4,545,620
62,262 -31.2% 151.48 ₩4,545,620
2009-12-04 2009-12-02 S Sale GenExel-Sein, Inc (제넥셀세인(주))

Unclassified position

Large shareholder
68,852 +44.9%
181.35
₩3,020,603
68,852 +44.9% 181.35 ₩3,020,603
2009-11-03 2009-11-02 B Purchase KIM JAESEOB (김 재섭)

Director (이사)

Director Large shareholder
22,952 +38.3%
335.66
₩1,803,175
22,952 +38.3% 335.66 ₩1,803,175